Upgrade to SI Premium - Free Trial

Pfizer (PFE) Announces EU Approval of Biosimilar TRAZIMERA

July 31, 2018 6:10 AM
Pfizer Inc. (NYSE: PFE) today announced the European Commission (EC) has approved TRAZIMERA™,1 a biosimilar to Herceptin®* (trastuzumab), for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA

Next Articles